FINIBAX Side Effects

6968642-7 | Platelet Count Decreased
on Sep 02, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Finibax dosage: . During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6628461-8 | Convulsion
Patient was taking Finibax (View Usage). Patient had the following side effects: convulsion on Mar 02, 2010 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with sepsis (What is sepsis?) and. Finibax dosage: .

6614032-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased
Adverse event was reported on Feb 19, 2010 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with postoperative wound infection, infection prophylaxis, bacterial infection (What is bacterial infection?) and. Location: JAPAN , 66 years of age, After Finibax was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased. During the same period patient was treated with CEFAMEZIN (View Cefamezin Review and Cefamezin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ZYVOX (View Zyvox Review and Zyvox Label ), MEROPENEM TRIHYDRATE (View Meropenem Trihydrate Review and Meropenem Trihydrate Label ).

6600999-9 | Renal Failure Acute
on Feb 16, 2010 Female patient from JAPAN , 90 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Finibax dosage: . During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ). Patient was hospitalized.


6484368-0 | Renal Impairment
on Nov 27, 2009 Male patient from JAPAN , 80 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). Patient had the following side effects: renal impairment. Finibax dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ZOSYN (View Zosyn Review and Zosyn Label ). Patient was hospitalized.

6444122-2 | Pancytopenia
Patient was taking Finibax (View Usage). After Finibax was administered, patient had the following side effects: pancytopenia on Nov 09, 2009 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with cholecystitis acute and. Finibax dosage: .

6418950-3 | Pyrexia
Adverse event was reported on Oct 16, 2009 by a Female patient taking Finibax (View Usage) (Dosage: ) was diagnosed with infection prophylaxis and. Location: JAPAN , 50 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia. During the same period patient was treated with FLOMOXEF SODIUM (View Flomoxef Sodium Review and Flomoxef Sodium Label ). Patient was hospitalized.

6277957-X | Renal Failure
on Jul 14, 2009 Female patient from JAPAN , 81 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). Patient had the following side effects: renal failure. Finibax dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ).

6194476-X | Liver Disorder
on May 14, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). After Finibax was administered, patient had the following side effects: liver disorder. Finibax dosage: .

6135115-3 | Angina Pectoris, Haemolytic Anaemia, Pancytopenia
Patient was taking Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, haemolytic anaemia, pancytopenia on Mar 18, 2009 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with subcutaneous abscess and. Finibax dosage: .

6094841-5 | Interstitial Lung Disease
Adverse event was reported on Feb 18, 2009 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with pneumonia bacterial and. Location: JAPAN , 64 years of age, Patient had the following side effects: interstitial lung disease.

6076423-4 | Haematuria
on Feb 04, 2009 Female patient from JAPAN , 67 years of age, was treated with Finibax (View Usage). After Finibax was administered, patient had the following side effects: haematuria. Finibax dosage: .

6068321-7 | Interstitial Lung Disease
on Jan 29, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with gastroenteritis (What is gastroenteritis?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Finibax dosage: 0.25 G X 3. During the same period patient was treated with CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ). Patient was hospitalized.

5991110-6 | Blood Creatinine Increased
Patient was taking Finibax (View Usage). Patient had the following side effects: blood creatinine increased on Dec 03, 2008 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 141.8 lb, was diagnosed with fungal infection (What is fungal infection?), febrile neutropenia and. Finibax dosage: . During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), AMBISOME (View Ambisome Review and Ambisome Label ), CYCLOCIDE (View Cyclocide Review and Cyclocide Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), FUNGUARD (View Funguard Review and Funguard Label ), CONCENTRATED HUMAN RED BLOOD CELLS (View Concentrated Human Red Blood Cells Review and Concentrated Human Red Blood Cells Label ).

5953319-7 | Blood Creatinine Increased
Adverse event was reported on Nov 03, 2008 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with fungal infection (What is fungal infection?), febrile neutropenia and. Location: JAPAN , 61 years of age, weighting 141.8 lb, After Finibax was administered, patient had the following side effects: blood creatinine increased. During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), CYCLOCIDE (View Cyclocide Review and Cyclocide Label ), AMBISOME (View Ambisome Review and Ambisome Label ), FUNGUARD (View Funguard Review and Funguard Label ), CONCENTRATED HUMAN RED BLOOD CELLS (View Concentrated Human Red Blood Cells Review and Concentrated Human Red Blood Cells Label ).

5878025-9 | Anaemia, White Blood Cell Count Decreased
on Jun 30, 2008 Female patient from JAPAN , 80 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, white blood cell count decreased. Finibax dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), PL (View Pl Review and Pl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ELCITONIN (View Elcitonin Review and Elcitonin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5864110-4 | Blood Pressure Decreased, Shock
on Aug 27, 2008 Male patient from JAPAN , 58 years of age, was diagnosed with biliary tract infection and was treated with Finibax (View Usage). Patient had the following side effects: blood pressure decreased, shock. Finibax dosage: .

5813252-8 | Anaemia, White Blood Cell Count Decreased
Patient was taking Finibax (View Usage). After Finibax was administered, patient had the following side effects: anaemia, white blood cell count decreased on Jul 11, 2008 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Finibax dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), PL (View Pl Review and Pl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ELCITONIN (View Elcitonin Review and Elcitonin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), CALONAL (View Calonal Review and Calonal Label ).

5806935-7 | Anaemia, White Blood Cell Count Decreased
Adverse event was reported on Jun 30, 2008 by a Female patient taking Finibax (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 80 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, white blood cell count decreased. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), PL (View Pl Review and Pl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ELCITONIN (View Elcitonin Review and Elcitonin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), CALONAL (View Calonal Review and Calonal Label ).

5752173-6 | Liver Disorder, Sepsis, Stevens-johnson Syndrome
on Jul 05, 2007 Male patient from JAPAN , 70 years of age, was diagnosed with infection (What is infection?), convulsion, sputum retention, wound complication, intercostal neuralgia, constipation (What is constipation?) and was treated with Finibax (View Usage). Patient had the following side effects: liver disorder, sepsis (What is sepsis?), stevens-johnson syndrome. Finibax dosage: . During the same period patient was treated with FLUMARIN (View Flumarin Review and Flumarin Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), SPELEAR (View Spelear Review and Spelear Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MAGMITT (View Magmitt Review and Magmitt Label ).

5662900-4 | Respiratory Failure
on Mar 04, 2008 Male patient from JAPAN , 80 years of age, was diagnosed with pneumonia aspiration and was treated with Finibax (View Usage). After Finibax was administered, patient had the following side effects: respiratory failure. Finibax dosage: . During the same period patient was treated with DUROTEP (View Durotep Review and Durotep Label ), PREDONINE (View Predonine Review and Predonine Label ), BLOPRESS (View Blopress Review and Blopress Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ).

5622006-7 | Blood Sodium Increased, Blood Urea Increased, Diabetes Mellitus, Disease Progression
Patient was taking Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium increased, blood urea increased, diabetes mellitus, disease progression on Feb 06, 2008 from JAPAN Additional patient health information: Male patient , weighting 97.00 lb, was diagnosed with pneumonia (What is pneumonia?), prophylaxis, diabetes mellitus and. Finibax dosage: . During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), AUGMENTIN '250' (View Augmentin '250' Review and Augmentin '250' Label ), MAGMITT (View Magmitt Review and Magmitt Label ), GLIMICRON (View Glimicron Review and Glimicron Label ).

5613623-9 | Oculomucocutaneous Syndrome
Adverse event was reported on Jan 25, 2008 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with sinusitis (What is sinusitis?) and. Location: JAPAN , 60 years of age, Patient had the following side effects: oculomucocutaneous syndrome. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), RULID (View Rulid Review and Rulid Label ), ALLEGRA (View Allegra Review and Allegra Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5595412-7 | Pancytopenia
on Jan 11, 2008 Female patient from JAPAN , 69 years of age, was diagnosed with pyrexia and was treated with Finibax (View Usage). After Finibax was administered, patient had the following side effects: pancytopenia. Finibax dosage: . During the same period patient was treated with CEFEPIME DIHYDROCHLORIDE HYDRATE (View Cefepime Dihydrochloride Hydrate Review and Cefepime Dihydrochloride Hydrate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BRIPLATIN (View Briplatin Review and Briplatin Label ). Patient was hospitalized.

5593383-0 | Blood Creatinine Increased, Blood Urea Increased, Liver Disorder
on Oct 16, 2007 Male patient from JAPAN , 59 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, liver disorder. Finibax dosage: . During the same period patient was treated with MAXIPIME (View Maxipime Review and Maxipime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ALKERAN (View Alkeran Review and Alkeran Label ), RITUXAN (View Rituxan Review and Rituxan Label ), GASTER D (View Gaster D Review and Gaster D Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

5583793-X | Muscle Spasms
Patient was taking Finibax (View Usage). Patient had the following side effects: muscle spasms on Dec 27, 2007 from JAPAN Additional patient health information: Male patient , 91 years of age, was diagnosed with burn infection and. Finibax dosage: . Patient was hospitalized.

5581292-2 | Convulsion
Adverse event was reported on Dec 26, 2007 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with bile duct stone, pyrexia and. Location: JAPAN , 74 years of age, After Finibax was administered, patient had the following side effects: convulsion. Patient was hospitalized.

5576712-3 | Renal Failure Acute
on Dec 25, 2007 Male patient from JAPAN , 81 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Finibax (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Finibax dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

5570935-5 | Enterocolitis Haemorrhagic
on Dec 17, 2007 Male patient from JAPAN , 65 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Finibax (View Usage). Patient had the following side effects: enterocolitis haemorrhagic. Finibax dosage: .

5511432-2 | Blood Creatinine Decreased
Patient was taking Finibax (View Usage). After Finibax was administered, patient had the following side effects: blood creatinine decreased on Oct 31, 2007 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Finibax dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), UNIPHYL LA (View Uniphyl La Review and Uniphyl La Label ), DASEN (View Dasen Review and Dasen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), TERSIGAN (View Tersigan Review and Tersigan Label ), CERCINE (View Cercine Review and Cercine Label ), LAC B (View Lac-b Review and Lac-b Label ). Patient was hospitalized.

5505471-5 | Hyperglycaemia
Adverse event was reported on Oct 23, 2007 by a Male patient taking Finibax (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: hyperglycaemia.

5505239-X | Liver Disorder
on Oct 23, 2007 Male patient from JAPAN , 89 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Finibax (View Usage). Patient had the following side effects: liver disorder. Finibax dosage: . Patient was hospitalized.

5431538-6 | Respiratory Failure
on Aug 16, 2007 Male patient from JAPAN , 80 years of age, was diagnosed with pneumonia aspiration and was treated with Finibax (View Usage). After Finibax was administered, patient had the following side effects: respiratory failure. Finibax dosage: . During the same period patient was treated with DUROTEP (View Durotep Review and Durotep Label ), PREDONINE (View Predonine Review and Predonine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ).